MentionFox
Home › Executive changes › Iterum Therapeutics plc
Leadership changes · ITRM · SEC Form 8-K, Item 5.02

Leadership changes at Iterum Therapeutics plc (2026)

Before you join, sell to or invest in Iterum Therapeutics plc

MentionFox check on Iterum Therapeutics plc: 1 red flag found in 2 sources (checked 14 November 2026). mentionfox.com/c/executive-changes/iterum-therapeutics

  • Bankruptcy filing disclosed Mar 2026 (filing)

Check Iterum Therapeutics plc before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Iterum Therapeutics plc?

Who joined and who left Iterum Therapeutics plc (ITRM)? 1 filing reported on 2026-03-27, each cited to the company's own filing.

As of November 14, 2026, Iterum Therapeutics plc has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 27, 2026 (Form 8-K, March 27, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

1 more record on Iterum Therapeutics plc ↓

Sell to companies like Iterum Therapeutics plc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Latest filing2026-03-27

Iterum Therapeutics plc reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-27. Every row below is cited to the filing it comes from, and this page adds each new change as Iterum Therapeutics plc files it.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-03-27Reportednot named in the filing8-K, 2026-03-27

Selling to them or working with them? See who runs Iterum Therapeutics plc now and the warning signs.

Free to see. No signup.

Keep reading

More on Iterum Therapeutics plc and the records around it.

Iterum Therapeutics plc elsewhere on the record

Want the whole picture on Iterum Therapeutics plc?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Iterum Therapeutics plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Iterum Therapeutics plc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.
Selling to Iterum Therapeutics plc?

New leaders reset buying decisions — get the Full Report on Iterum Therapeutics plc: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Iterum Therapeutics plc

Hiring for a seat like this?

Find people with the same kind of experience as the senior executive at Iterum Therapeutics plc, with the record behind each one.

Find candidates like senior executive at Iterum Therapeutics plc

Every change, in the filing's words

Filed 2026-03-27 · 8-K

Reported

On March 27, 2026, and effectively immediately upon the appointment of the Joint Provisional Liquidators, the executive authority of the Board of Directors ceased and executive authority passed to the Joint Provisional Liquidators.

Also stated in this filing

  • Also on March 27, 2026, each of Corey Fishman, the Company's President and Chief Executive Officer, and Judith Matthews, the Company's Chief Financial Officer, resigned from their positions with the Company, effective as of immediately following the filing of the Winding Up Petition.

Tools for this story

Each opens in a new tab, filled in for Iterum Therapeutics plc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/iterum-therapeutics
Last updated 2026-11-14
Primary record: SEC filing
What changed at the top of Iterum Therapeutics plc? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/iterum-therapeutics